Top compounds associated with response to OR2D3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.005
mRNA A-443654 GDSC1000 pan-cancer AAC 0.14 0.006
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.007
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.083 0.008
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.008
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.008
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC 0.14 0.008
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.12 0.009
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC 0.11 0.01
mRNA linifanib CTRPv2 pan-cancer AAC -0.088 0.01
Download CSV